Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized Cross-over Trial of Veverimer and Sodium Bicarbonate on Muscle Mitochondrial Energetics and Physical Endurance in Chronic Kidney Disease and Metabolic Acidosis

Next Previous
Trial Profile

Randomized Cross-over Trial of Veverimer and Sodium Bicarbonate on Muscle Mitochondrial Energetics and Physical Endurance in Chronic Kidney Disease and Metabolic Acidosis

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 26 May 2026

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sodium bicarbonate (Primary) ; Veverimer (Primary)
  • Indications Metabolic acidosis
  • Focus Therapeutic Use
  • Acronyms Senergy-CKD

Most Recent Events

  • 06 May 2026 Planned End Date changed from 30 Jul 2026 to 31 Dec 2026.
  • 06 May 2026 Planned primary completion date changed from 31 Dec 2025 to 31 Dec 2026.
  • 16 Aug 2023 Planned initiation date (estimated date of first participant enrollment) changed from 1 Apr 2023 to 1 Jun 2023. changed from 1 Jun 2023 to 8 Sep 2023.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top